Emtricitabine and gamma-glutamyltransferase increased 
Emtricitabine and gamma-glutamyltransferase increased Patient Reports February 11, 2012
Emtricitabine Side Effects Report #4676809-6
Emtricitabine side effect was reported by a Consumer or non-health professional from on May 12, 2005. Female patient, 43 years of age, weighting 168.0 lb, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, eructation, fatigue, gamma-glutamyltransferase increased, hepatic steatosis. Emtricitabine dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with LOPINAVIR, BACTRIM DS, LISINOPRIL, ASPIRIN, GLUCOPHAGE, TRICOR, NOVOLIN. Patient was hospitalized. Patient recovered.Emtricitabine Side Effects Report #4593987-8
Emtricitabine side effect was reported by a Consumer or non-health professional from on Feb 01, 2005. Female patient, 23 years of age, weighting 165.3 lb, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, dyspnoea, feeling hot and cold, gamma-glutamyltransferase increased, influenza like illness, lethargy, liver function test abnormal. Emtricitabine dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, ATAZANAVIR, RITONAVIR, DAPSONE, METHADONE. Patient recovered.Emtricitabine Side Effects Report #4561237-4
Emtricitabine side effect was reported by a Consumer or non-health professional from on Jan 06, 2005. Male patient, 14 years of age, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood bilirubin unconjugated increased, fatigue, gamma-glutamyltransferase increased, headache , ocular icterus, thirst. Emtricitabine dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ATAZANAVIR, RITONAVIR, DIDANOSINE. Patient recovered.Emtricitabine Side Effects Report #4629246-4
Emtricitabine side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, 14 years of age, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood amylase increased, blood bilirubin increased, blood bilirubin unconjugated increased, fatigue, gamma-glutamyltransferase increased, headache , hyperglycaemia. Emtricitabine dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ATAZANAVIR, RITONAVIR, DIDANOSINE. Patient recovered.Emtricitabine Side Effects Report #4650869-0
Emtricitabine side effect was reported by a Consumer or non-health professional from on Apr 18, 2005. Male patient, 14 years of age, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood amylase increased, blood bilirubin increased, blood bilirubin unconjugated increased, fatigue, gamma-glutamyltransferase increased, glucose urine present. Emtricitabine dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ATAZANAVIR, RITONAVIR, DIDANOSINE. Patient recovered.Emtricitabine Side Effects Report #4751825-4
Emtricitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 15, 2004. Female patient, weighting 168.2 lb, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bilirubin conjugated increased, gamma-glutamyltransferase increased, hepatic steatosis, hypoaesthesia, lactic acidosis, ocular icterus, rash pustular. Emtricitabine dosage: unknown. During the same period patient was treated with LOPINAVIR, BACTRIM DS, LISINOPRIL, ASPIRIN, GLUCOPHAGE, TRICOR, NOVOLIN. Patient was hospitalized. Patient recovered.